Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion type Assertion NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_head.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion description "[PAX2 is a potential therapeutic gene target in renal cancer and suggest that adjunctive PAX2 knockdown may enhance the efficacy of other chemotherapeutic agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_provenance.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion evidence source_evidence_literature NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_provenance.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion SIO_000772 18439754 NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_provenance.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion wasDerivedFrom lhgdn-20090331 NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_provenance.
- NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_assertion wasGeneratedBy ECO_0000203 NP195880.RA1wct-upYGzEp4Gf_LA-N8SKJ4OFqxfOR2V3UvLbC034130_provenance.